Anne Wojcicki
Co-Founder and CEO at 23andMe.
Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new
drugs and diagnostics. Presently, 23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.
Visit website: https://www.crunchbase.com/person/anne-wojcicki
See also: 23andMe - Home DNA testing kit.
Details last updated 21-Jan-2021
Anne Wojcicki News
23andMe acquired virtual healthcare firm Lemonaid Health for $400M
pharmaphorum - 25-Oct-2021
Merger to improve remote health services and offer personalised treatment plans
Read more...Can Google solve death?
Time Magazine - 30-Sep-2013
Google CEO Larry Page discusses the launch of Calico. Will focus on health and aging in particul...
Read more...